References
Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;63:e1–e60.
Sharp MT, Horn TD. Pseudoporphyria induced by voriconazole. J Am Acad Dermatol 2005;53:341–345.
Dolan CK, Hall MA, Blazes DL, Norwood CW. Pseudoporphyria as a result of voriconazole use: a case report. Int J Dermatol 2004;43:768–771.
Willis ZI, Boyd AS, Di Pentima MC. Phototoxicity, pseudoporphyria, and photo-onycholysis due to voriconazole in a pediatric patient with leukemia and invasive aspergillosis. J Pediatric Infect Dis Soc 2015;4:e22–e24.
Zhang XM, Yin T, Dong SJ, Wang LY, Jiang LD, Sun HY. Discussion on etiology and pathogenesis of pulmonary aspergillosis and differentiation treatment of TCM. Chin J Tradit Chin Med Pharm (Chin) 2014;29:2507–2509.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jia, My., Han, Cs. & Zhang, Sn. Integrated Chinese and Western Medicines Shorten Treatment Course of Subacute Invasive Pulmonary Aspergillosis: A Case Report. Chin. J. Integr. Med. 26, 307–309 (2020). https://doi.org/10.1007/s11655-020-3186-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-020-3186-4